We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$109B
AUM Growth
+$6.58B
Cap. Flow
-$2.53B
Cap. Flow %
-2.32%
Top 10 Hldgs %
11.22%
Holding
2,919
New
123
Increased
1,147
Reduced
1,380
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 17.78%
2 Industrials 13.97%
3 Financials 11.99%
4 Consumer Discretionary 10.9%
5 Healthcare 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGIO
2601
DELISTED
Edgio, Inc. Common Stock
EGIO
$63K ﹤0.01%
457
+15
+3% +$1.78K
ARAY icon
2602
Accuray
ARAY
$34M
$59K ﹤0.01%
12,301
-13,732
-53% -$66.2K
LCTX icon
2603
Lineage Cell Therapeutics
LCTX
$278M
$58K ﹤0.01%
23,539
-574
-2% -$1.34K
NRDY icon
2604
Nerdy
NRDY
$96.7M
$56K ﹤0.01%
+12,400
New +$88.6K
PGEN icon
2605
Precigen
PGEN
$2.59B
$56K ﹤0.01%
15,038
-460
-3% -$1.98K
MKFG
2606
DELISTED
Markforged Holding Corporation
MKFG
$55K ﹤0.01%
1,027
-1,029
-50% -$65.5K
AKBA icon
2607
Akebia Therapeutics
AKBA
$252M
$53K ﹤0.01%
23,670
-677
-3% -$1.85K
GERN icon
2608
Geron
GERN
$949M
$53K ﹤0.01%
43,555
-1,167
-3% -$1.67K
WKHS icon
2609
Workhorse Group
WKHS
$36.3M
$52K ﹤0.01%
+4
New +$72.7K
RIGL icon
2610
Rigel Pharmaceuticals
RIGL
$750M
$51K ﹤0.01%
1,916
-57
-3% -$1.72K
VSTM icon
2611
Verastem
VSTM
$610M
$51K ﹤0.01%
2,076
-48
-2% -$1.51K
CECO icon
2612
Ceco Environmental
CECO
$4.14B
$50K ﹤0.01%
7,957
+436
+6% +$2.89K
WGS icon
2613
GeneDx Holdings
WGS
$2.3B
$50K ﹤0.01%
340
-9
-3% -$2.01K
SPIR icon
2614
Spire Global
SPIR
$555M
$49K ﹤0.01%
1,831
-55
-3% -$2.23K
CLVS
2615
DELISTED
Clovis Oncology, Inc.
CLVS
$48K ﹤0.01%
17,774
+1,078
+6% +$3.98K
KOPN icon
2616
Kopin
KOPN
$791M
$47K ﹤0.01%
11,534
-268
-2% -$1.36K
NEXT icon
2617
NextDecade
NEXT
$1.78B
$47K ﹤0.01%
16,573
-148
-0.9% -$494
XERS icon
2618
Xeris Biopharma Holdings
XERS
$1.45B
$47K ﹤0.01%
+15,965
New +$34.5K
BODI icon
2619
The Beachbody Company
BODI
$74.8M
$46K ﹤0.01%
387
-14
-3% -$2.7K
BBIG
2620
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$45K ﹤0.01%
1,378
+402
+41% +$23.5K
BIOR
2621
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$45K ﹤0.01%
87
+30
+53% +$21.5K
LITS
2622
Lite Strategy Inc
LITS
$30.9M
$44K ﹤0.01%
824
+140
+20% +$7.81K
BKCC
2623
DELISTED
BlackRock Capital Investment Corporation
BKCC
$43K ﹤0.01%
10,761
-354
-3% -$1.48K
WTI icon
2624
W&T Offshore
WTI
$518M
$41K ﹤0.01%
12,634
-17,672
-58% -$68K
RNAC icon
2625
Cartesian Therapeutics
RNAC
$268M
$40K ﹤0.01%
407
-7
-2% -$753

Similar funds

Victory Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Victory Capital Management held 2,919 positions worth $109B, up 6.4% from $102B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Victory Capital Management's Q4 2021 filing shows 123 new, 1,147 increased, 1,380 reduced and 157 closed positions. Its largest new stake was Victory Portfolios II VictoryShares Core Plus Bond ETF: 7,796,100 shares worth $194M. The largest sale was HILL-ROM HOLDINGS, INC., an estimated $373M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q4 2021 buy was Victory Portfolios II VictoryShares Core Plus Bond ETF: 7,796,100 shares worth $194M.
  • Victory Capital Management added most to Global Payments in Q4 2021, an estimated $382M increase.
  • Victory Capital Management's biggest Q4 2021 reduction was Highwoods Properties, cutting an estimated $199M.
  • Victory Capital Management fully exited HILL-ROM HOLDINGS, INC. in Q4 2021, selling an estimated $373M.
  • Victory Capital Management's ten largest holdings make up 11% of its $109B portfolio in Q4 2021.
  • Victory Capital Management opened 123 new positions and closed 157 in Q4 2021.
  • Victory Capital Management's portfolio value rose 6.4% quarter-over-quarter to $109B.

Based on Victory Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.